This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Mosaic (MOS) Benefits from Higher Demand, Cost Reductions
by Zacks Equity Research
Mosaic (MOS) gains on strong demand for phosphate and potash on the back of favorable agricultural market fundamentals.
Nutrien's (NTR) Q2 Earnings Lag Estimates, Revenues Beat
by Zacks Equity Research
Nutrien (NTR) earnings are adversely impacted by unprecedented volatility in global crop input markets in Q2.
Nutrien (NTR) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
Although the revenue and EPS for Nutrien (NTR) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Nutrien (NTR) Misses Q2 Earnings Estimates
by Zacks Equity Research
Nutrien (NTR) delivered earnings and revenue surprises of -10.60% and 4.24%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Mosaic (MOS) Q2 Earnings Lag Estimates
by Zacks Equity Research
Mosaic (MOS) delivered earnings and revenue surprises of -2.80% and 6.72%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Nutrien (NTR) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
The impact of weak fertilizer prices may have affected Nutrien's (NTR) performance in the second quarter.
Analysts Estimate Nutrien (NTR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Nutrien (NTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nutrien (NTR) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Nutrien (NTR) closed at $64.26 in the latest trading session, marking a -0.06% move from the prior day.
Nutrien (NTR) Gains on Higher Demand Amid Pricing Woes
by Zacks Equity Research
Nutrien (NTR) is positioned to benefit from rising fertilizer demand, bolstered by production enhancements and acquisitions, while also addressing challenges posed by lower prices.
Nutrien (NTR) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Nutrien (NTR) closed at $59.82, marking a -0.4% move from the previous day.
Nutrien (NTR) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Nutrien (NTR) closed at $59.27, marking a +0.29% move from the previous day.
Nutrien (NTR) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Nutrien (NTR) closed at $59.70, marking a -1.49% move from the previous day.
Should You Invest in the VanEck Agribusiness ETF (MOO)?
by Zacks Equity Research
Sector ETF report for MOO
Nutrien (NTR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Nutrien (NTR) closed at $59.63 in the latest trading session, marking a +1.91% move from the prior day.
Why Is Nutrien (NTR) Down 4.5% Since Last Earnings Report?
by Zacks Equity Research
Nutrien (NTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Nutrien (NTR) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Nutrien (NTR) closed at $58.94 in the latest trading session, marking a -0.67% move from the prior day.
Here's Why You Should Hold Onto Nutrien (NTR) Stock for Now
by Zacks Equity Research
Nutrien (NTR) gains on healthy demand for crop nutrients on the strength in global agriculture markets amid challenges from lower fertilizer prices.
Caterpillar and Nutrien have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Caterpillar and Nutrien have been highlighted as Zacks Bull and Bear of the Day.
Bear of the Day: Nutrien Ltd. (NTR)
by Derek Lewis
Negative earnings estimate revisions from analysts and weak quarterly results paint a challenging picture for the company's shares in the near term.
Is Nutrien (NTR) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Nutrien (NTR) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Bunge (BG) to Boost Sustainable Practices With Nutrien Tie-Up
by Zacks Equity Research
Bunge (BG) forms a partnership with Nutrien Ag Solutions to expand sustainable agriculture.
Nutrien (NTR) Misses Earnings and Revenue Estimates in Q1
by Zacks Equity Research
Nutrien (NTR) results in the first quarter are affected by lower realized selling prices across its segments and reduced sales volumes in Retail, Potash and Phosphate units.
Compared to Estimates, Nutrien (NTR) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Nutrien (NTR) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Novo Nordisk and Nutrien have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Novo Nordisk and Nutrien are part of the Zacks Bull and Bear of the Day article.
Bear of the Day: Nutrien, Ltd. (NTR)
by Bryan Hayes
Higher costs are expected to impact company margins.